1. 8th European Conference on Rare Diseases & Orphan Products (ECRD 2016). Issue 1 (November 2016) Authors: Schlander, Michael; Holm, Søren; Nord, Erik; Richardson, Jeff; Garattini, Silvio; Kolominsky-Rabas, Peter; Marshall, Deborah; Persson, Ulf; Postma, Maarten; Simoens, Steven; de Solà Morales, Oriol; Tolley, Keith; Toumi, Mondher; Telser, Harry; Bonham, James; Hintner, Helmut; Diem, Anja; Laimer, M... Journal: Orphanet journal of rare diseases Issue: Volume 11:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe. (February 2014) Authors: Schlander, Michael; Adarkwah, Charles Christian; Gandjour, Afschin Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 15:Number 1(2015) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost of decentralized CAR T‐cell production in an academic nonprofit setting. Issue 12 (6th July 2020) Authors: Ran, Tao; Eichmüller, Stefan B.; Schmidt, Patrick; Schlander, Michael Journal: International journal of cancer Issue: Volume 147:Issue 12(2020) Page Start: 3438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost‐effectiveness of risk‐based breast cancer screening: A systematic review. Issue 4 (1st May 2021) Authors: Khan, Shah Alam; Hernandez‐Villafuerte, Karla Vanessa; Muchadeyi, Muchandifunga Trust; Schlander, Michael Journal: International journal of cancer Issue: Volume 149:Issue 4(2021) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor. (February 2014) Authors: Gandjour, Afschin; Gafni, Amiram; Schlander, Michael Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 1(2014) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement. Issue 1 (1st January 2016) Authors: Schlander, Michael; Garattini, Silvio; Kolominsky-Rabas, Peter; Nord, Erik; Persson, Ulf; Postma, Maarten; Richardson, Jeff; Simoens, Steven; Solà-Morales, Oriol de; Tolley, Keith; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Do certified cancer centers provide more cost‐effective care? A health economic analysis of colon cancer care in Germany using administrative data. Issue 10 (27th July 2021) Authors: Cheng, Chih‐Yuan; Datzmann, Thomas; Hernandez, Diego; Schmitt, Jochen; Schlander, Michael Journal: International journal of cancer Issue: Volume 149:Issue 10(2021) Page Start: 1744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare childhood disease [CLN2]. (19th May 2022) Authors: Moro, Domenico; Schlander, Michael; Telser, Harry; Sola-Morales, Oriol; Clark, Michael David; Olaye, Andrew; Camp, Charlotte; Jain, Mohit; Butt, Thomas; Bakshi, Sumeet Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 22:Number 4(2022) Page Start: 581 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health technology assessment (HTA) and economic evaluation: efficiency or fairness first. Issue 1 (1st January 2019) Authors: Richardson, Jeff; Schlander, Michael Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Income loss after a cancer diagnosis in Germany: An analysis based on the socio‐economic panel survey. (10th May 2021) Authors: Hernandez, Diego; Schlander, Michael Journal: Cancer medicine Issue: Volume 10:Number 11(2021) Page Start: 3726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗